Investment Trust Centre
HomeAstraZeneca: CALLA Phase III Trial for Imfinzi fails to achieve statistical significanceAstraZeneca-Chart-24-3-22

AstraZeneca-Chart-24-3-22

AstraZeneca Chart 24-3-22

Most Read

Get in Touch

Legals

My account

Latest Stories

Shares

Seraphim Space IT investee company gets significant German contract

Shares

AIM movers: Strix transforms balance sheet with Billi sale and good news for Caledonia Mining

News

WH Smith shares fall as profits evaporate

Shares

AIM movers: Tekmar contract and Surgical Innovations hit by flu

Shares

FTSE 100 flat after UK interest rates cut to 3.75%

© UK Investor Group UK Investor and UK Investor Magazine are registered trademarks of UK Investor Group Ltd (09932115) | All rights reserved